Akademik Veri Yönetim Sistemi
Turkiye Klinikleri Journal of Medical Sciences, cilt.43, sa.3, ss.314-322, 2023 (Scopus)
Objective: Cancer also causes psychological problems. Sleep disorders, depression and anxiety are common in cancer patients. In this study, we aimed to determine the frequency of sleep disorders, depression and anxiety in patients with early-stage breast cancer, who receive hormone therapy or are under follow-up. Material and Methods: The study was conducted in an outpatient setting using the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Hospital Anxiety and Depression (HAD) Scale. Results: Eighty patients were included in the study. The patients median age was 55 years. All patients had diagnoses of early-stage (Stage 1, Stage 2, Stage 3) breast cancer. No patient was receiving chemotherapy. 22 (27.5%) patients were followed without treatment, 58 (72.5%) patients had hormone therapy [(26 (44.8%) patients tamoxifen, 32 (55.1%) aromatase inhibitors, 12 (20.6%) patients gonadotropin receptor agonist)]. There were 59 (73.8%) patients in natural or iatrogenic menopause, and 21 (26.3%) premenopausal patients. According to the results of the survey, the frequency of sleep disorder was 37.5% with PSQI, 45.5% with ISI; depression was 35% and anxiety disorder was 58.8% with HAD Scale. There was no difference in the results of the questionnaire between the groups according to the hormone therapy used and menopause status. Conclusion: The frequency of sleep disorders, depression and anxiety disorders was found to be high in the patient group diagnosed with early-stage breast cancer, even if the patients were not on chemotherapy. It is important that all cancer patients are referred for psychological evaluation and, if necessary, treatment.